Modified Sano's classification
OtherSet of characteristics described by Singh et al. 2013 to evaluate colorectal lesions.
Other names: MS classification
NCT Number: NCT02963207
OBJECTIVE: Our study aimed to compare a recently-developed endoscopic classification with an established one for colorectal lesions in a randomised trial between 2013 and 2015.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
OBJECTIVE: Current practice requires histopathological assessment to confirm diagnosis for colorectal lesions detected at colonoscopy. Advances in endoscopic imaging contribute for real-time diagnosis which, apart from being cost and time-saving, also guides decision-making and reduces risks. Our study aimed to compare a recently-developed endoscopic classification with an established one.
DESIGN: The modified Sano's classification (MS) was compared to the Narrow Band Imaging (NBI) International Colorectal Endoscopic classification (NICE) in a randomised trial between 2013 and 2015. An experimented endoscopist classified each polyp, what was compared to histopathology.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Set of characteristics described by Singh et al. 2013 to evaluate colorectal lesions.
Other names: MS classification
Set of characteristics described by Hewett et al. 2012 to evaluate colorectal lesions.
Other names: NBI International Colorectal Endoscopic Classification
Time frame: After two weeks of the colonoscopy
Comparison of NICE or MS with the final histopathology in regards to polyps' subtype (i.e. non-neoplastic = Hyperplastic Polyp (HP) and neoplastic = Sessile Serrated Adenoma/Polyp (SSA/P), Adenomatous Polyp (AP), Traditional Serrated Adenoma (TSA), superficial cancer and invasive cancer)
Time frame: After two weeks of the colonoscopy
Comparison of NICE or MS with the final histopathology in regards to invasiveness (SSA/P, AP, TSA or superficial cancer versus invasive cancer)
Time frame: After two weeks of the colonoscopy
Comparison of MS with the final histopathology in regards to SSA/P (SSA/P versus non-SSA/P)
Time frame: After two weeks of the colonoscopy
Comparison of NICE or MS with the final histopathology in regards to <5 mm distal to the sigmoid polyps (NPV for HPs - according to the PIVI guidelines)
Time frame: Immediately after the colonoscopy (endoscopic) and 2 weeks after (histopathology)
Comparison of NICE or MS with the final histopathology in regards to prediction of surveillance interval (according to the PIVI guidelines)
Lyell McEwin Hospital
Other Gov
Prospective Randomised Study Comparing Modified Sano's (MS) Classification and NBI International Colorectal Endoscopic (NICE) for Differentiating Colorectal Lesions
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06791395
Colonic Diseases, Colorectal Neoplasms
Changchun, Jilin, China
View Trial DetailsNCT07517848
Colo-rectal Cancer, Colonic Diseases
Manisa, Turkey (Türkiye)
View Trial DetailsNCT04192565
Colonic Diseases, Colorectal Adenoma
Santo André, São Paulo, Brazil
View Trial DetailsNCT05576506
Colonic Diseases, Colorectal Adenoma
Jinan, Shandong, China
View Trial Details